Page 32 - 2020-2021-Heroes-Program-Bklt-v1_fa_Neat
P. 32
Judith Deal
Judith has been with Pfizer for over 32 years and is currently a Principal Scientist. She received a
B.S. in Chemistry from Penn State. While at Pfizer, she has contributed to discovery efforts which
led to cancer therapies Inlyta (axitinib), Lorbrena (lorlatinib), and PF-07220060, which is currently
in clinical trials.
Bob Dugger
Bob received his B.S. from the University of Missouri St. Louis in 1975 followed by his Ph.D. from the
University of California Berkeley in 1980. After teaching for six years at Miami University, he moved
to Pfizer’s Chemical Research and Development group where he worked until retiring in 2019.
Mingying He
Mingying He is a Senior Scientist at Pfizer and has an M.S. from Syracuse University.
Jacqui Hoffman
Jacqui Hoffman received a B.S. in Chemistry from Illinois Wesleyan University, and started her
research career with Pharmacia in Kalamazoo, MI in 2001. She is currently a Principal Scientist
within Oncology Medicinal Chemistry at Pfizer in La Jolla, CA, and was a recipient of an
ACS Technical Achievement Awards (TAOC) award in 2015.
32 #HeroesofChemistry
